Sign in

CIK 0000728387

  • Non-accelerated filer
  • Smaller reporting company

Perspective Therapeutics, Inc.

Sign in to watch
Ticker
CATX
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
411458152
Phone
+1 206-676-0900
Business address
2401 ELLIOTT AVENUE, SUITE 320, SEATTLE, WA, 98121
Former names
IsoRay, Inc., Isoray, Inc., CENTURY PARK PICTURES CORP
Open-market buys, last 90 days
$142,436
in 6 filings
Open-market sales, last 90 days
$1,622,534
in 5 filings

Net −$1,480,098. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-11-11 Spoor Johan M. Chief Executive Officer Purchase +47,000 $0.81 $38K 106,383
2026-03-02 Spoor Johan M. Chief Executive Officer Grant or award · Stock option (right to buy) +735,000 735,000
2025-03-28 Spoor Johan M. Chief Executive Officer Purchase +22,026 $2.24 $49K 59,383
2025-03-28 Spoor Johan M. Chief Executive Officer Purchase +4,650 $2.21 $10K 4,650
2025-03-03 Spoor Johan M. Chief Executive Officer Grant or award · Stock option (right to buy) +650,000 650,000
2024-12-04 Spoor Johan M. CEO Purchase +8,000 $3.77 $30K 36,257
2024-11-25 Spoor Johan M. CEO Purchase +14,500 $3.78 $55K 152,072
2024-11-25 Spoor Johan M. CEO Purchase +5,400 $3.80 $21K 5,400
2024-11-25 Spoor Johan M. CEO Purchase +6,600 $3.80 $25K 66,600
2024-06-20 Spoor Johan M. CEO Grant or award · Stock option (right to buy) +500,000 500,000
2024-06-13 Spoor Johan M. CEO Purchase +100,000 $1.17 $117K 137,572
2023-12-12 Spoor Johan M. CEO Grant or award · Stock Options (right to buy) +3,338,878 11,793,635

Page 1 of 1 · 12 trades